Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone.
D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000201:enzymology / Q000209:etiology*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000175:diagnosis / Q000201:enzymology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008099:Liver / Q000201:enzymology; D008875:Middle Aged; D000077205:Pioglitazone; D013844:Thiazoles / Q000009:adverse effects*; D045162:Thiazolidinediones; D000637:Transaminases / Q000097:blood
D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000637:Transaminases; D001663:Bilirubin; D000077205:Pioglitazone